在基于生物信息学分析和门德尔随机化分析的骨关节炎中识别生物标志物和潜在的药物标
Feng Cheng1,2, Mengying Li1, Haotian Hua1
1The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Frontiers in pharmacology
|September 13, 2024
概括
这项研究确定了ARL4C和GAPDH作为潜在的诊断生物标志物和骨关节炎 (OA) 的治疗点. 这些基因有望开发新的个性化治疗方法,以管理与OA相关的慢性关节疼痛.
科学领域:
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨关节炎 (OA) 导致慢性关节疼痛,目前没有治疗方法.
- 生物信息学和门德尔随机化 (MR) 是药物发现的关键.
- 鉴定OA的新型诊断标志物和治疗点至关重要.
研究的目的:
- 为了确定骨关节炎的新型诊断生物标志物.
- 发现改善的药物向部位用于骨关节炎治疗.
- 为了利用生物信息学和MR用于治疗目标识别.
主要方法:
- 通过基因表达综合 (GEO) 数据库收集了来自突膜,软骨和子突骨的基因表达数据.
- 采用两样MR分析来评估表达定量特征位置 (eQTL) 对OA的因果关系.
- 综合GEO数据和MR分析以确定核心基因,随后进行生物信息学查和分子实验验证.
主要成果:
- 通过对GEO和MR数据的联合分析,确定了五个重要的基因.
- 生物信息学分析将这些基因与免疫功能联系起来.
- 确定ARL4C和GAPDH是OA表达减少的核心基因,在MR分析中显示出保护作用和有利的药物相互作用.
结论:
- ARL4C和GAPDH被确定为骨关节炎的潜在诊断生物标志物.
- 这些基因代表了个性化OA治疗的有希望的治疗标.
- 该研究验证了GEO和MR用于识别新型OA药物标的使用.
相关概念视频
Genome-wide Association Studies-GWAS
13.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.2K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K


